Skip Main Navigation

| | nCounter PanCancer Progression Panel

nCounter® PanCancer Progression Panel


A Multiplexed Gene Expression Approach to Evaluating Metastasis

The nCounter PanCancer Progression Panel is a new panel developed to assist researchers with the challenge of assessing cancer progression. The panel has 770 genes from four major biological processes that contribute to increased tumor growth and invasiveness, including angiogenesis, the epithelial-to-mesenchymal transition, extracellular matrix remodeling, and metastasis.

  • Investigate the state of cancer progression
  • Measure treatment effects on angiogenesis
  • Assess the extracellular matrix and remodeling mechanisms
  • Detect key genes that mark the epithelial-to-mesenchymal transition
  • Quantify the expression of metastatic growth and suppressor genes

PanCancer Progression

Distribution of Genes in the PanCancer Progression Panel

770 genes including angiogenesis, extracellular matrix, epithelial-to-mesenchymal transition, and metastasis. Components of each feature are highlighted.

Request Information | E-mail us: | Call us: 1 888 358 6266